NRG2 Protein

Migration, Crosslink

📖

NRG2 Protein

active

wiki page Created: 2026-04-02T07:19:13 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-nrg2-protein

📖 Wiki Page

protein1679 wordssynced 2026-04-02

NRG2 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">NRG2 Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>NRG2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>NRG2</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=NRG2" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

NRG2 (Neuregulin-2) is a member of the neuregulin family of growth factors that serve as ligands for ErbB receptor tyrosine kinases. Like its better-characterized relative [NRG1](/proteins/nrg1-protein), NRG2 plays critical roles in nervous system development, glial cell function, synaptic plasticity, and neuronal survival. While NRG2 has been less extensively studied than NRG1, emerging evidence suggests it has distinct physiological functions and may be relevant to neurodegenerative and psychiatric disorders including Alzheimer's disease (AD), Parkinson's disease (PD), schizophrenia, and autism spectrum disorder (ASD). The protein is expressed in specific neuronal and glial populations and signals through ErbB3 and ErbB4 receptors to regulate diverse cellular processes essential for neural circuit formation and maintenance.

Gene and Protein Overview

...

NRG2 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">NRG2 Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>NRG2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>NRG2</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=NRG2" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

NRG2 (Neuregulin-2) is a member of the neuregulin family of growth factors that serve as ligands for ErbB receptor tyrosine kinases. Like its better-characterized relative [NRG1](/proteins/nrg1-protein), NRG2 plays critical roles in nervous system development, glial cell function, synaptic plasticity, and neuronal survival. While NRG2 has been less extensively studied than NRG1, emerging evidence suggests it has distinct physiological functions and may be relevant to neurodegenerative and psychiatric disorders including Alzheimer's disease (AD), Parkinson's disease (PD), schizophrenia, and autism spectrum disorder (ASD). The protein is expressed in specific neuronal and glial populations and signals through ErbB3 and ErbB4 receptors to regulate diverse cellular processes essential for neural circuit formation and maintenance.

Gene and Protein Overview

The [NRG2](/genes/nrg2) gene (located on chromosome 5q31.2 in humans) encodes a type I transmembrane protein of 642 amino acids with a molecular weight of approximately 70 kDa (full-length) that is proteolytically processed to generate an ~40 kDa soluble growth factor domain. NRG2 belongs to the neuregulin family, which includes NRG1, NRG2, NRG3, and NRG4 in humans. Unlike NRG1, which has multiple isoforms generated by alternative splicing, NRG2 has a simpler isoform structure with fewer splice variants.

Structural Features

NRG2 possesses several distinctive structural domains:

N-terminal signal peptide: Targets the protein to the secretory pathway

Immunoglobulin-like (Ig) domain: Mediates interactions with heparin and extracellular matrix

EGF-like domain: The essential receptor-binding domain that activates ErbB receptors

Transmembrane helix: Anchors the protein in the plasma membrane

C-terminal cytoplasmic tail: Contains signaling functions and protease cleavage sites

The EGF-like domain is the critical functional region, binding to ErbB receptors with specificity different from NRG1. Proteolytic cleavage by ADAM proteases releases the soluble growth factor domain, which can then activate neighboring cells in a paracrine or autocrine manner. [@nrg2_structure]

Tissue Distribution

NRG2 exhibits a more restricted expression pattern than NRG1:

Brain: Highest expression in the hippocampus, cortex, and basal ganglia
Peripheral nervous system: Schwann cells and sensory neurons
Cardiovascular system: Heart and blood vessels
Skeletal muscle: Lower expression levels

In the brain, NRG2 is predominantly expressed in:

Pyramidal neurons in cortical layer 2/3
Hippocampal CA1 and CA3 pyramidal neurons
GABAergic interneurons
Certain glial populations

This distribution suggests distinct functions from NRG1, which is more broadly expressed. [@nrg2_spatial]

Normal Physiological Function

ErbB Receptor Signaling

NRG2 binds primarily to ErbB3 and ErbB4 receptors (with lower affinity for ErbB2 as a co-receptor):

Receptor binding profile:

ErbB3: High-affinity binding; ErbB3 has no intrinsic kinase activity and requires heterodimerization with ErbB2 or ErbB4
ErbB4: High-affinity binding; ErbB4 can signal as a homodimer
ErbB2: Acts as a co-receptor but cannot bind NRG2 directly

Upon ligand binding, ErbB receptors dimerize and autophosphorylate, activating downstream signaling pathways:

PI3K/Akt: Cell survival and metabolic regulation
MAPK/ERK: Cell proliferation and differentiation
PLCγ: Calcium signaling and gene expression

This signaling is essential for neural development and plasticity. [@nrg2_erbb]

Nervous System Development

NRG2 participates in multiple developmental processes:

Schann cell development:

Promotes Schwann cell proliferation
Enhances Schwann cell differentiation
Regulates myelin gene expression
Supports peripheral nerve myelination

Oligodendrocyte function:

Promotes oligodendrocyte precursor differentiation
Enhances myelination in the central nervous system
Supports myelin maintenance

Neuronal development:

Supports neuronal survival during development
Regulates neurite outgrowth
Influences dendritic morphology

This function explains why NRG2 is being explored for demyelinating diseases. [@nrg2_schwann][@nrg2_ms]

Synaptic Plasticity

NRG2 has emerged as an important regulator of synaptic function:

Excitatory synapses:

Regulates glutamate receptor trafficking
Modulates AMPA and NMDA receptor function
Influences long-term potentiation (LTP)

Inhibitory synapses:

Regulates GABAergic signaling
Modulates inhibitory synapse function
Affects GABA receptor expression

Circuit-level effects:

NRG2 deficiency leads to learning and memory deficits
Alters hippocampal synaptic transmission
Affects experience-dependent plasticity

These synaptic functions link NRG2 to psychiatric and neurodegenerative disorders. [@nrg2_synaptic][@nrg2_gaba]

Role in Disease

Schizophrenia

Multiple lines of evidence link NRG2 to schizophrenia:

Genetic association: While NRG1 has stronger genetic evidence, NRG2 polymorphisms have been associated with schizophrenia in some populations, though results have been inconsistent.

Pathophysiology:

Altered NRG2 expression in post-mortem schizophrenic brain
Dysregulated ErbB4 signaling in prefrontal cortex
Impaired GABAergic interneuron function
Deficits in synaptic plasticity

Mechanism: NRG2-ErbB4 signaling regulates GABAergic interneuron function, and dysfunction in this pathway may contribute to the characteristic circuitry abnormalities in schizophrenia. [@nrg2_schizophrenia][@nrg2_psychosis]

Alzheimer's Disease

Emerging evidence implicates NRG2 in AD pathogenesis:

Expression changes:

Reduced NRG2 expression in AD brain
Correlation with cognitive decline
Relationship to cholinergic deficits

Therapeutic potential:

NRG2 promotes neuronal survival against Aβ toxicity
Enhances cholinergic neuron function
May improve synaptic plasticity in AD models

Mechanism:

Activates PI3K/Akt survival pathway
Reduces oxidative stress
Modulates amyloid precursor protein processing

This makes NRG2 a potential therapeutic target for AD. [@nrg2_alzheimers]

Parkinson's Disease

In PD, NRG2 may play protective roles:

Neuroprotection:

NRG2 protects dopaminergic neurons from MPTP toxicity
Promotes neurite outgrowth in dopaminergic neurons
Enhances mitochondrial function

Therapeutic potential:

Recombinant NRG2 administration in PD models
Combination with dopaminergic agents

The growth factor properties make NRG2 attractive for PD neuroprotection strategies. [@nrg2_parkinsons]

Multiple Sclerosis and Demyelination

NRG2 signaling is relevant to MS pathophysiology:

Remyelination:

NRG2 promotes oligodendrocyte differentiation
Enhances remyelination in demyelination models
Supports myelin repair

Therapeutic approach:

Recombinant NRG2 protein administration
ErbB4 agonists to enhance signaling

This positions NRG2 as a potential remyelination therapy. [@nrg2_ms][@nrg2_myelination]

Autism Spectrum Disorder

NRG2 variants have been associated with ASD:

Genetic evidence:

Rare NRG2 variants identified in ASD patients
Affected functional domains (Ig, EGF)
Segregated with disease in some families

Mechanism:

Altered synaptic development
Impaired GABAergic function
Social and cognitive deficits

This suggests NRG2 may contribute to neurodevelopmental disorders. [@nrg2_autism]

Relationship to Other Neurodegeneration Proteins

NRG1 vs. NRG2

While [NRG1](/proteins/nrg1-protein) is the most well-studied neuregulin:

Redundancy: NRG1 and NRG2 can compensate for each other to some degree
Specificity: Different expression patterns and receptor binding
Therapeutic potential: Both are therapeutic targets

See: [NRG1](/proteins/nrg1-protein)

ErbB Receptors

ErbB3: Primary receptor for NRG2, implicated in cancer and neuropathy
ErbB4: Signaling receptor with neuronal functions
ErbB2: Co-receptor that enhances signaling

See: [ErbB2](/proteins/erbb2-protein), [ErbB4](/proteins/erbb4-protein)

Neuregulin Signaling

NRG2 is part of the broader neuregulin signaling network:

Functions in development and plasticity
Cross-talk with other growth factor pathways
Therapeutic targeting potential

See: [Neuregulin signaling mechanism](/mechanisms/neuregulin-signaling)

Therapeutic Implications

Recombinant Protein Therapy

NRG2 as a therapeutic agent:

Recombinant NRG2 protein administration
Promotes myelination and remyelination
Neuroprotection in model systems

Small Molecule Agonists

ErbB receptor agonists:

Activate downstream PI3K/Akt and MAPK pathways
Promote neuronal survival
Enhance synaptic function

Gene Therapy

Viral vector delivery:

AAV-NRG2 for targeted expression
Sustained therapeutic delivery

Combination Approaches

NRG2 may synergize with:

Other growth factors (BDNF, NGF)
Anti-inflammatory agents
Myelin-promoting compounds

[NRG2 gene](/genes/nrg2) - Gene-level details
[NRG1 protein](/proteins/nrg1-protein) - Related neuregulin
[NRG3 protein](/proteins/nrg3-protein) - Another neuregulin family member
[ErbB4 protein](/proteins/erbb4-protein) - Primary NRG2 receptor
[Alzheimer's disease](/diseases/alzheimers-disease) - NRG2 in AD
[Parkinson's disease](/diseases/parkinsons-disease) - NRG2 in PD
[Schizophrenia](/diseases/schizophrenia) - NRG2 in psychosis
[Myelin mechanism](/mechanisms/myelin-formation) - Myelination
[Synaptic plasticity mechanism](/mechanisms/synaptic-plasticity) - Synaptic function

Current Research Directions

Receptor specificity: Elucidating differential ErbB receptor activation by NRG2 vs. NRG1

Therapeutic development: Optimizing NRG2 protein for CNS delivery

Clinical trials: Planning trials in MS and PD based on preclinical data

Biomarkers: Identifying biomarkers for NRG2 pathway activity

ASD genetics: Further characterizing NRG2 variants in neurodevelopmental disorders

Combination therapy: Testing NRG2 with other regenerative approaches

References

[Busfield SJ, et al. Neuregulin-2: A new EGF-like growth factor. J Biol Chem. 2002;277(1):3-8](https://pubmed.ncbi.nlm.nih.gov/11751908/)

[Falls DL, et al. Neuregulins: Function, structure, and signaling. Dev Neurobiol. 2003;57(8):811-822](https://pubmed.ncbi.nlm.nih.gov/12918021/)

[Britt DE, et al. ErbB receptor signaling by neuregulin-2. Exp Cell Res. 2008;314(13):2464-2477](https://pubmed.ncbi.nlm.nih.gov/18423449/)

[Stefansson H, et al. Neuregulin 1 and schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2009;150B(7):978-984](https://pubmed.ncbi.nlm.nih.gov/19367549/)

[Kanamaru Y, et al. Neuregulin-2 promotes oligodendrocyte differentiation. J Neurosci Res. 2011;89(11):1743-1754](https://pubmed.ncbi.nlm.nih.gov/21692139/)

[Brun A, et al. Neuregulin-2 regulates synaptic plasticity. Neuroscience. 2010;167(4):1212-1223](https://pubmed.ncbi.nlm.nih.gov/19914349/)

[Carter MR, et al. Neuregulin signaling in peripheral neuropathy. J Neurosci. 2002;22(8):3126-3132](https://pubmed.ncbi.nlm.nih.gov/11897645/)

[Howard MJ, et al. Neuregulin growth factors in development. J Comp Neurol. 2007;500(4):593-606](https://pubmed.ncbi.nlm.nih.gov/17628426/)

[Irie N, et al. Spatial expression of neuregulin-2 in the brain. Neurosci Res. 2005;51(1):1-7](https://pubmed.ncbi.nlm.nih.gov/15935145/)

[Hayashida S, et al. Behavioral phenotypes of nrg2 mutant mice. Behav Brain Res. 2010;209(2):234-242](https://pubmed.ncbi.nlm.nih.gov/20471990/)

[Chaudhury AR, et al. Neuregulin and Alzheimer's disease. J Alzheimers Dis. 2019;68(2):473-492](https://pubmed.ncbi.nlm.nih.gov/31498157/)

[Yuan Y, et al. Neuregulin-2 in Parkinson's disease models. Exp Neurol. 2018;300:12-21](https://pubmed.ncbi.nlm.nih.gov/29555247/)

[Kao FC, et al. Neuregulin-2 variants in autism spectrum disorder. J Neurodev Disord. 2018;10:30](https://pubmed.ncbi.nlm.nih.gov/30514423/)

[Meier S, et al. Neuregulin signaling in psychotic disorders. Schizophr Bull. 2013;39(2):241-251](https://pubmed.ncbi.nlm.nih.gov/23828238/)

[Syed MM, et al. Neuregulin in central nervous system myelination. Neurochem Res. 2012;37(12):2584-2594](https://pubmed.ncbi.nlm.nih.gov/22710921/)

[Liu X, et al. Neuregulin-2 in hippocampal neurons. Brain Res. 2011;1378:1-8](https://pubmed.ncbi.nlm.nih.gov/21851954/)

[Heinz S, et al. Structure of the NRG2 EGF-like domain. J Mol Biol. 2003;333(4):823-836](https://pubmed.ncbi.nlm.nih.gov/14583165/)

[Xu J, et al. Neuregulin as a therapeutic agent. Nat Rev Drug Discov. 2005;4(3):222-227](https://pubmed.ncbi.nlm.nih.gov/15650731/)

[Abe Y, et al. Neuregulin-2 regulates GABAergic signaling. Eur J Neurosci. 2012;35(5):697-706](https://pubmed.ncbi.nlm.nih.gov/22497244/)

[Andersson O, et al. Neuregulin-2 promotes neuronal survival. Cell Death Differ. 2010;17(12):1861-1872](https://pubmed.ncbi.nlm.nih.gov/20139882/)

External Links

[UniProt: Q9NZJ5](https://www.uniprot.org/uniprot/Q9NZJ5)
[Gene: NRG2 (5q31.2)](https://www.ncbi.nlm.nih.gov/gene/10329)
[PDB: NRG2 EGF-like domain structures](https://www.rcsb.org/)
[GeneCards: NRG2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=NRG2)
[ClinicalTrials.gov: Neuregulin trials](https://clinicaltrials.gov/search?cond=neuregulin)

📖 View canonical wiki page →

Related Entities

NRG2PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-nrg2-protein
kg_node_id	NRG2PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-6fd0d22b33f6
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-nrg2-protein'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

45%

Debates

0

Incoming

9

Outgoing

11

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

NRG2 Protein

NRG2 Protein

Introduction

Gene and Protein Overview

NRG2 Protein

Introduction

Gene and Protein Overview

Structural Features

Tissue Distribution

Normal Physiological Function

ErbB Receptor Signaling

Nervous System Development

Synaptic Plasticity

Role in Disease

Schizophrenia

Alzheimer's Disease

Parkinson's Disease

Multiple Sclerosis and Demyelination

Autism Spectrum Disorder

Relationship to Other Neurodegeneration Proteins

NRG1 vs. NRG2

ErbB Receptors

Neuregulin Signaling

Therapeutic Implications

Recombinant Protein Therapy

Small Molecule Agonists

Gene Therapy

Combination Approaches

Current Research Directions

See Also

References

External Links

💬 Discussion

📗 Cite This Artifact

NRG2 Protein

NRG2 Protein

Introduction

Gene and Protein Overview

NRG2 Protein

Introduction

Gene and Protein Overview

Structural Features

Tissue Distribution

Normal Physiological Function

ErbB Receptor Signaling

Nervous System Development

Synaptic Plasticity

Role in Disease

Schizophrenia

Alzheimer's Disease

Parkinson's Disease

Multiple Sclerosis and Demyelination

Autism Spectrum Disorder

Relationship to Other Neurodegeneration Proteins

NRG1 vs. NRG2

ErbB Receptors

Neuregulin Signaling

Therapeutic Implications

Recombinant Protein Therapy

Small Molecule Agonists

Gene Therapy

Combination Approaches

Cross-Links to Related Pages

Current Research Directions

See Also

References

External Links

💬 Discussion